Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of adding IPV or fractional IPV to the routine infant immunization program on sero-immunity and antibody titer
IRCT2017082327144N2Phase 3Completed
- Sponsor
- WHO Department of Immunization, Vaccines and Biologicals
- Start
- Sep 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of trivalent inactivated polio vaccine in poliomyelitis (2 arms), sponsored by WHO Department of Immunization, Vaccines and Biologicals. Primary endpoints: Sero-immunity, Antibody titer and 1 more. Started Sep 2017; status: completed.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on IRCT2017082327144N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017082327144N2.